Antibiotics Market by Class (Beta Lactam & Beta Lactamase, Quinolones, Macrolides, and Others), Drug Origin (Natural, Semisynthetic, and Synthetic), Spectrum of Activity (Broad-spectrum Antibiotic and Narrow-spectrum Antibiotic), and Route of Administration (Oral, Intravenous, and Others): Global Opportunity Analysis and Industry Forecast, 2018 - 2025
Antibiotics Market Overview :
The global antibiotics market generated $42,335 million in 2017, and is projected to reach $50,374 million by 2025, growing at a CAGR of 2.1% from 2018 to 2025.
Antibiotic is an antimicrobial substance, which are used in the treatment and prevention of bacterial infections, as well as used rarely to combat protozoan infections. Antibiotics are the medicines that either discontinue bacteria from growing or destroy bacteria straight referred as bacteriostatic and bactericidal antibiotics respectively. Easy accessibility of antibiotics at drug stores and in hospitals with prescription or without prescription fuels their consumption across the world. Moreover, increases antibiotics demand during transplants, dialysis, suppressed immune system, joint replacement, and others boosts the market growth.
Surge in demand for antibiotics, owing to increased consumption in low- & middle-income countries and rise in prevalence of infectious diseases are the key factors that boost the growth of the global antibiotics market. In addition, development of novel approaches for new antibiotics to treat bacterial infections and increase in clinical trials to determine safety & efficacy of the antibiotics drive the market growth. However, development of antibiotic resistance, driven by misuse of antibiotics, and time taken for regulatory approval are projected to impede the market growth. On the contrary, discovery of advanced prospect molecules and introduction of novel combination therapies to treat antibiotic-resistant microbial infections are expected to offer lucrative opportunities for the market players.
The global antibiotics market is segmented based on class, drug origin, spectrum of activity, route of administration, and region. On the basis of class, the market is classified as beta lactam & beta lactamase inhibitors, macrolides, quinolones, and others. The beta lactam & beta lactamase inhibitors segment is further segmented into penicillin, cephalosporin, monobactam, and carbapenem. Depending on drug origin, the antibiotics market is categorized into natural, semisynthetic, and synthetic. According to the spectrum of activity, it is bifurcated into broad-spectrum antibiotic and narrow-spectrum antibiotic. Based on route of administration, it is segregated into oral, intravenous, and others. Region wise, the market is studied across North America, Europe, Asia-Pacific, and LAMEA.
Key Benefits for Antibiotics Market :
This report provides a detailed quantitative analysis of the current market trends and future estimations from 2018 to 2025, which assists to identify the prevailing market opportunities.
An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
A comprehensive analysis of the factors that drive and restrain the growth of the global antibiotics market is provided.
An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.
Antibiotics Key Market Segments :
Beta Lactam & Beta Lactamase Inhibitors
By Drug Origin
By Spectrum of Activity
By Route of Administration
Rest of Europe
Rest of Asia-Pacific
Rest of LAMEA
KEY MARKET PLAYERS
F. Hoffmann-La Roche Ltd.
Merck & Co. Inc.
Novartis International AG (Sandoz)
Teva Pharmaceutical Industries Ltd.
The other players in the value chain include (profiles not included in the report):
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook